Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-swqlm Total loading time: 1.114 Render date: 2021-12-08T00:52:57.803Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

9 - Oesophagus

Published online by Cambridge University Press:  23 December 2009

Tom Crosby
Affiliation:
Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
Louise Hanna
Affiliation:
Velindre Hospital, Cardiff
Tom Crosby
Affiliation:
Velindre Hospital, Cardiff
Fergus Macbeth
Affiliation:
Velindre Hospital, Cardiff
Get access

Summary

Introduction

In the past few decades there has been a dramatic increase in the incidence of adenocarcinoma of the oesophagus, predominantly in the lower oesophagus and gastro-oesophageal junction. This trend has been noted across most patient populations worldwide but is most noticeable in the younger, white male population, where it would appear to be related to gastro-oesophageal reflux disease (GORD) and to be less strongly associated with alcohol and smoking. Meanwhile, the incidence of squamous cancer worldwide has remained steady or fallen slightly, though there are large geographical variations.

The majority of patients present with symptoms of locally advanced or metastatic disease, which limits survival from any treatment. Combined modality therapy is increasingly used in these cases. Chemoradiation is more effective than radiotherapy alone and there is some evidence that preoperative chemotherapy is superior to surgery alone. There is a continuing controversy about the exact role of surgery combined with chemoradiotherapy and which one should be used as the primary therapy. Clinical trials are currently trying to define the optimum radiotherapy and chemotherapy regimens.

Types of oesophageal tumour

The types of oesophageal tumours are shown in Table 9.1.

The oesophagus is a relatively common site for a second primary cancer. For instance, following successful treatment for head and neck cancer, 4% of patients per year develop a second primary, 30% of which are oesophageal, especially squamous cancers.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bates, B. A., Detterbeck, F. C., Bernard, S. A.et al. (1996). Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J. Clin. Oncol., 14, 156–63.CrossRefGoogle ScholarPubMed
Bedenne, L., Michel, P., Bouche, O.et al. (2002). Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc. Am. Soc. Clin. Oncol., Abstr 519.Google Scholar
Blazeby, J., Farndon, J., Donovan, J.et al. (2000). A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer, 88, 1781–7.3.0.CO;2-G>CrossRefGoogle ScholarPubMed
Bosset, J. F., Gignoux, M., Triboulet, J. P.et al. (1997). Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N. Engl. J. Med., 337, 161–7.CrossRefGoogle ScholarPubMed
Cooper, J. S., Guo, M. D., Herskovic, A.et al. (1999). Chemoradiotherapy of locally advanced esophageal cancer: long term follow-up of a prospective randomized trial (Radiation Therapy Oncology Group 85–01). J. A. M. A., 281, 1623–7.CrossRefGoogle Scholar
Crosby, T. D., Brewster, A. E., Borley, A.et al. (2004). Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br. J. Cancer., 90, 70–5.CrossRefGoogle ScholarPubMed
Denham, J. W., Steigler, A., Kilmurray, J.et al. (2003). Relapse patterns after chemoradiation for carcinoma of the oesophagus. Clin. Oncol. (R. Coll. Radiol.), 15, 98–108.CrossRefGoogle Scholar
Earlam, R. and Cunha-Melo, J. R. (1980). Oesophageal squamous cell carcinoma: II. A critical view of radiotherapy. Br. J. Surg., 67, 457–61.CrossRefGoogle Scholar
Geh, J., Bond, S., Bentzen, S.et al. (2000). Preoperative chemoradiotherapy in esophageal cancer: evidence of dose response. Proc. Am. Soc. Clin. Oncol., Abstr 958.Google Scholar
Kelsen, D. P., Ginsberg, R., Pajak, T. F.et al. (1998). Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N. Engl. J. Med., 339, 1979–84.CrossRefGoogle ScholarPubMed
Kobori, O., Kirihara, Y., Kosaka, N.et al. (1999). Positron emission tomography of esophageal carcinoma using 11C-choline and 18F-flurodeoxyglucose: a novel method of preoperative lymphnode staging. Cancer, 86, 1638–48.3.0.CO;2-U>CrossRefGoogle Scholar
Luketich, J. D., Schauer, P. R., Meltzer, C. C.et al. (1997). Role of positron emission tomography in staging esophageal cancer. Ann. Thoracic Surg., 64, 765–9.CrossRefGoogle ScholarPubMed
Malthaner, R. and Fenlon, D. (2004). Preoperative chemotherapy for resectable thoracic esophageal cancer (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.Google Scholar
Medgyesy, C. D., Wolff, R. A., Putnam, J. B. Jr.et al. (2000). Small cell carcinoma of the esophagus: the University of Texas M.D. Anderson Cancer Center experience and literature review. Cancer, 88, 262–7.3.0.CO;2-K>CrossRefGoogle Scholar
Medical Research Council Oesophageal Cancer Working Group. (2002). Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet, 359, 1727–33.CrossRef
Minsky, B. D., Pajak, T. F., Ginsberg, R. J.et al. (2002). INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J. Clin. Oncol., 20, 1167–74.CrossRefGoogle ScholarPubMed
Stahl, M., Wilke, H., Fink, U.et al. (1996). Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: Interim analysis of phase II trial. J. Clin. Oncol., 14, 829–37.CrossRefGoogle ScholarPubMed
Sykes, A. J., Burt, P. A., Slevin, N. J.et al. (1998). Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother. Oncol., 48, 15–21.CrossRefGoogle Scholar
International Union Against Cancer. (2002). In tumour nodes metastases Classification of Malignant Tumours, ed. Sobin, L. H. and Ch., Wittekind, 6th edn. New York: Wiley-Liss, pp. 60–4.Google Scholar
Urba, S. G., Orringer, M. B., Turrisi, A.et al. (2001). Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J. Clin. Oncol., 19, 305–13.CrossRefGoogle ScholarPubMed
Walsh, T., Noonan, N., Hollywood, D.et al. (1996). A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N. Engl. J. Med., 335, 462–7.CrossRefGoogle ScholarPubMed
Webb, A., Cunningham, D., Scarffe, J. H.et al. (1997). Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J. Clin. Oncol., 15, 261–7.CrossRefGoogle ScholarPubMed
Wong, R. and Malthaner, R. (2005). Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review). In The Cochrane Library, Issue 2. Oxford: Update Software.Google Scholar

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Oesophagus
    • By Tom Crosby, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
  • Edited by Louise Hanna, Tom Crosby, Fergus Macbeth
  • Book: Practical Clinical Oncology
  • Online publication: 23 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545375.010
Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

  • Oesophagus
    • By Tom Crosby, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
  • Edited by Louise Hanna, Tom Crosby, Fergus Macbeth
  • Book: Practical Clinical Oncology
  • Online publication: 23 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545375.010
Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

  • Oesophagus
    • By Tom Crosby, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
  • Edited by Louise Hanna, Tom Crosby, Fergus Macbeth
  • Book: Practical Clinical Oncology
  • Online publication: 23 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545375.010
Available formats
×